Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brexit

Set Alert for Brexit

UK Set For January Brexit After Conservatives Win Election

The Conservative Party's victory in the UK general election means the Brexit withdrawal deal will be able to pass. The UK will leave the EU by 31 January and enter a transition period during which medicines regulation will remain broadly unchanged.

United Kingdom Brexit Regulation

Scotland Wants NHS Protected From Post-Brexit Trade Deals

The Scottish National Party has put the NHS, EU membership and Scottish independence at the heart of its campaign as the UK prepares to vote in the 12 December general election.

United Kingdom Healthcare Systems Pricing Debate

Latest From Brexit

UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System

At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing EU rules that have been transposed into domestic legislation, it also wants the freedom to tailor its regulations in areas like clinical trials, advanced therapies and product labeling.

United Kingdom Regulation

UK MHRA Looks Beyond Brexit Transition

Now that the UK has left the EU, the UK’s medicines regulator says it will use the rest of this year to work out how best to ensure continuity of drug regulation after the Brexit transition period ends on 31 December.

Brexit Regulation

EU Parliament Urges Post-Brexit Cooperation On Medicines

Life science companies will be pleased to hear that the European Parliament is pressing for close cooperation between the UK and the EU in the area of medicines regulation.

Brexit Europe

UK Medicines And Medical Devices Bill Laid Before Parliament

UK health minister Baroness Blackwood will introduce the new UK Medicines and Medical Devices Bill before Parliament today, just before the House of Commons goes into recess. The government wants new legislation for devices and medicines in place before the end of the Brexit transition period.

United Kingdom Regulation

Analyzing An EU Medtech Regulation Crisis In The Making

EU medical device consultant Trevor Lewis takes note of the recent, if belated, progress towards the building of the post-MDR playing field for medical device companies in Europe, but calls political decision-makers and economic operators to account: getting it right is nothing short of a matter of life and death, he tells In Vivo.

EU Market Access

Novartis And UK Launch Partnership On Groundbreaking Cardiovascular Prevention Trial

Partnership includes provision for fast-tracked uptake of inclisiran in England, if NICE finds it cost effective.

United Kingdom Companies

European Medicines Agency Counts The Cost Of Brexit

As the EMA settles into its permanent headquarters in Amsterdam, it hopes that new recruits will swell its depleted staff numbers. But much will depend on the necessary expertise being available, particularly following the loss of access to experts working at the UK regulator, the MHRA. 

Europe Brexit

Device Week, 7 February 2020 – UK's Brexit From EU Creates Medtech Uncertainties

In this week's podcast, Medtech Insight executive editor Ashley Yeo chats with deputy editor Reed Miller about the UK's departure from the EU on 31 January, and what that means for the region's medtech industry.

Device Week Regulation

Drug Prices ‘Not On The Table’ In UK-US Trade Deal Talks

As the UK prepares for talks on post-Brexit free trade agreements with the EU and other countries around the world, the life science industry has called for a specific pharmaceutical annex in any FTAs. 

United Kingdom United States
See All
UsernamePublicRestriction

Register